Literature DB >> 16012713

Suppression of beta-catenin mutation by dietary exposure of auraptene, a citrus antioxidant, in N,N-diethylnitrosamine-induced hepatocellular carcinomas in rats.

Akira Hara1, Keiko Sakata, Yasuhiro Yamada, Toshiya Kuno, Nami Kitaori, Takeru Oyama, Yoshinobu Hirose, Akira Murakami, Takuji Tanaka, Hideki Mori.   

Abstract

Alteration of beta-catenin expression in hepatocellular carcinomas (HCCs) may play an important role in tumor progression by stimulating cell proliferation. We have previously reported that auraptene (AUR), an antioxidant agent isolated from citrus fruit, effectively inhibits chemically induced hepatocarcinogenesis in rats. In this study, we investigated the molecular mechanism of the inhibitory effects of dietary supplementation with AUR on N,N-diethylnitrosamine (DEN)-initiated hepatocarcinogenesis. Male F344 rats initiated with DEN were fed the AUR-containing diet during either the initiation stage (initiation feeding for 7 weeks) or post-initiation phase (post-initiation feeding for 25 weeks) of hepatocarcinogenesis. Liver tumors >5 mm in diameter were used for the analysis of beta-catenin gene mutation and beta-catenin protein expression. After PCR amplification of exon 2 of the beta-catenin gene, the products were sequenced directly. Mutations in the beta-catenin gene were detected in 8 of 24 HCCs (33.3%) in the DEN alone group, 7 of 15 HCCs (46.7%) in the DEN + AUR (initiation feeding) group, and 0 of 8 HCCs (0%) in the DENright curved arrow AUR (post-initiation feeding) group. No mutations of beta-catenin gene were detected in liver cell adenomas of any group. These results demonstrate that AUR exposure in post-initiation period suppresses the occurrence of HCCs with beta-catenin mutation, presumably by negative selection for neoplastic cells harboring the mutation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16012713

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  13 in total

1.  Relationship between XRCC1 and XPD polymorphisms and the risk of the development of hepatocellular carcinoma: A case-control study.

Authors:  Tao Yuan; Shaoli Deng; Hongming Liu; Menggang Liu; Ping Chen
Journal:  Exp Ther Med       Date:  2012-05-17       Impact factor: 2.447

2.  Chemopreventive potential of beta-Sitosterol in experimental colon cancer model--an in vitro and In vivo study.

Authors:  Albert A Baskar; Savarimuthu Ignacimuthu; Gabriel M Paulraj; Khalid S Al Numair
Journal:  BMC Complement Altern Med       Date:  2010-06-04       Impact factor: 3.659

3.  Auraptene Attenuates Malignant Properties of Esophageal Stem-Like Cancer Cells.

Authors:  Saffiyeh Saboor-Maleki; Fatemeh B Rassouli; Maryam M Matin; Mehrdad Iranshahi
Journal:  Technol Cancer Res Treat       Date:  2016-05-20

4.  Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells.

Authors:  G Ramakrishnan; L Lo Muzio; C M Elinos-Báez; S Jagan; T A Augustine; S Kamaraj; P Anandakumar; T Devaki
Journal:  Cell Prolif       Date:  2009-04       Impact factor: 6.831

5.  Dietary supplementation of silymarin is associated with decreased cell proliferation, increased apoptosis, and activation of detoxification system in hepatocellular carcinoma.

Authors:  Ramakrishnan Gopalakrishnan; Jagan Sundaram; Kamaraj Sattu; Anandakumar Pandi; Devaki Thiruvengadam
Journal:  Mol Cell Biochem       Date:  2013-02-09       Impact factor: 3.396

6.  Prevention of N-nitrosodiethylamine-induced hepatocarcinogenesis by S-allylcysteine.

Authors:  Sivapatham Sundaresan; Perumal Subramanian
Journal:  Mol Cell Biochem       Date:  2008-01-06       Impact factor: 3.396

7.  Auraptene, a Major Compound of Supercritical Fluid Extract of Phalsak (Citrus Hassaku Hort ex Tanaka), Induces Apoptosis through the Suppression of mTOR Pathways in Human Gastric Cancer SNU-1 Cells.

Authors:  Jeong Yong Moon; Hyeonji Kim; Somi Kim Cho
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-13       Impact factor: 2.629

8.  Citrus auraptene suppresses cyclin D1 and significantly delays N-methyl nitrosourea induced mammary carcinogenesis in female Sprague-Dawley rats.

Authors:  Prasad Krishnan; Karen J Yan; David Windler; Jesse Tubbs; Robert Grand; Benjamin D L Li; C Marcelo Aldaz; Jerry McLarty; Heather E Kleiner-Hancock
Journal:  BMC Cancer       Date:  2009-07-29       Impact factor: 4.430

9.  Effects of Auraptene on IGF-1 Stimulated Cell Cycle Progression in the Human Breast Cancer Cell Line, MCF-7.

Authors:  Prasad Krishnan; Heather Kleiner-Hancock
Journal:  Int J Breast Cancer       Date:  2012-12-18

10.  Novel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitors.

Authors:  Riccardo Zanni; Maria Galvez-Llompart; Cecilia Morell; Nieves Rodríguez-Henche; Inés Díaz-Laviada; Maria Carmen Recio-Iglesias; Ramon Garcia-Domenech; Jorge Galvez
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.